Potassium Chloride Tablet Franchise in Ahmedabad

Potfil 750 mg Tablet Supplier in Mumbai

Electrolyte Supplement Tablet Distributor in Delhi

Potassium Chloride Tablet Manufacturer in Bangalore

Hypokalemia Tablet Stockist in Hyderabad
Potassium Chloride Tablet Exporter in Chandigarh

Home/Products /potassium-chloride-750mg-tablet

Potfil 750 Tablet

Composition : Potassium Chloride (750mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Potfil 750 Tablet contains Potassium Chloride 750 mg, an essential electrolyte supplement widely used for the treatment and prevention of hypokalemia (low potassium levels) caused by conditions such as prolonged diuretic therapy, gastrointestinal losses, or inadequate dietary intake.

Potassium plays a critical role in maintaining normal cellular function, nerve impulse transmission, muscle contraction, and cardiac rhythm. Supplementation with potassium chloride helps restore optimal serum potassium levels, thereby preventing complications such as muscle weakness, arrhythmias, and fatigue.

Clinically, Potfil 750 Tablet is prescribed in cardiology, nephrology, and general medicine practices, especially in patients receiving loop or thiazide diuretics, those with chronic illnesses, or individuals requiring long-term electrolyte management under medical supervision.

The tablet ensures accurate dosing, good gastrointestinal tolerance, and reliable electrolyte correction, making it suitable for hospitals, clinics, specialty pharmacies, and healthcare providers managing electrolyte imbalance and supportive care therapy.

Read More

About the Product

Potfil 750 Tablet contains Potassium Chloride 750 mg, an essential electrolyte supplement widely used for the treatment and prevention of hypokalemia (low potassium levels) caused by conditions such as prolonged diuretic therapy, gastrointestinal losses, or inadequate dietary intake.

Potassium plays a critical role in maintaining normal cellular function, nerve impulse transmission, muscle contraction, and cardiac rhythm. Supplementation with potassium chloride helps restore optimal serum potassium levels, thereby preventing complications such as muscle weakness, arrhythmias, and fatigue.

Clinically, Potfil 750 Tablet is prescribed in cardiology, nephrology, and general medicine practices, especially in patients receiving loop or thiazide diuretics, those with chronic illnesses, or individuals requiring long-term electrolyte management under medical supervision.

The tablet ensures accurate dosing, good gastrointestinal tolerance, and reliable electrolyte correction, making it suitable for hospitals, clinics, specialty pharmacies, and healthcare providers managing electrolyte imbalance and supportive care therapy.

Common side effects may include nausea, vomiting, abdominal discomfort, diarrhea, or gastric irritation. Rare but serious adverse effects include hyperkalemia, cardiac rhythm disturbances, and gastrointestinal ulceration, especially with improper dosing.

Potfil 750 Tablet is indicated for the treatment and prevention of hypokalemia (low potassium levels). It is commonly prescribed in patients receiving diuretics, those with gastrointestinal potassium loss, cardiac disorders, or conditions requiring potassium supplementation to maintain normal physiological function.

Potfil 750 Tablet should be taken strictly under medical supervision. Regular monitoring of serum potassium levels is recommended, particularly in patients with kidney disease, heart disorders, or those taking ACE inhibitors or potassium-sparing diuretics. Do not exceed the prescribed dose. Seek immediate medical attention if muscle weakness, irregular heartbeat, or severe gastrointestinal symptoms occur.

Store below 25°C in a dry place. Protect from moisture and direct sunlight. Keep out of reach of children. Do not use if the tablet shows signs of damage or discoloration.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation